What Blood Tests Do You Need on Ozempic?
Whether you're taking Ozempic, Wegovy, Mounjaro, or Zepbound — routine lab work provides vital context. Here is an educational overview of standard panels healthcare providers commonly monitor, what those markers reveal, and what circulating protein tests miss.
Essential Clinical Panels
Commonly Monitored by Clinicians
GLP-1 medications like Ozempic and Wegovy are powerful drugs that affect your liver, kidneys, thyroid, blood sugar, and cardiovascular system. Here are five core panels healthcare providers frequently evaluate alongside GLP-1 protocols to assess liver, kidney, metabolic, and cardiovascular health.
Comprehensive Metabolic Panel (CMP)
The CMP is your metabolic baseline. It checks 14 substances in your blood and is the single most important panel for anyone on GLP-1 therapy.
- ALT & AST — liver enzymes to catch drug-induced liver stress early
- BUN & Creatinine — kidney function, especially important with rapid weight loss
- Fasting Glucose — tracks glycemic response to medication
- Electrolytes — sodium, potassium, CO₂ balance during caloric restriction
Lipid Panel
GLP-1 drugs often improve lipid profiles dramatically — but monitoring is essential to quantify progress and adjust statin co-prescriptions if needed.
- LDL Cholesterol — primary cardiovascular risk marker
- HDL Cholesterol — protective lipoprotein, should rise with treatment
- Triglycerides — often the first lipid to improve on GLP-1 therapy
- Total Cholesterol — the big-picture lipid number
Thyroid Panel
GLP-1 receptor agonists carry an FDA boxed warning for thyroid C-cell tumors based on rodent studies. Thyroid monitoring isn't optional — it's required.
- TSH — the primary thyroid screening test
- Free T4 — measures active thyroid hormone levels
- Calcitonin — elevated levels can signal medullary thyroid carcinoma risk
Inflammatory Markers
GLP-1s have documented anti-inflammatory effects. Tracking inflammation markers helps quantify this benefit and can flag hidden issues like pancreatitis risk.
- hs-CRP — high-sensitivity C-reactive protein, a cardiovascular inflammation marker
- ESR — erythrocyte sedimentation rate, a general inflammation gauge
- Lipase & Amylase — pancreatic enzymes, critical for detecting early pancreatitis
Complete Blood Count (CBC)
The CBC is a general health screening that checks for anemia, infection, and blood disorders — all of which can be unmasked by rapid weight loss and caloric restriction.
- Hemoglobin & Hematocrit — catches anemia from nutritional deficiency
- WBC Count — immune function baseline while on therapy
- Platelet Count — overall hematologic health marker
HbA1c (Bonus)
Not technically part of the standard panels above, but your HbA1c (hemoglobin A1c) is the single best measure of long-term blood sugar control over 2–3 months.
- HbA1c — tracks average glucose over 2–3 months, the gold standard for diabetes management
- Fasting Insulin — reveals insulin resistance trends before glucose rises
What Standard Blood Tests
Completely Miss
Standard blood work measures static end products: single proteins, liver enzymes, or simple cell counts. When monitoring inflammation on GLP-1 medications, the standard go-to is hs-CRP — a single protein manufactured by your liver hours after an inflammatory signal has already propagated.
hs-CRP has a ~19-hour half-life, rises in response to almost any acute or chronic trigger, and is completely blind to which immune programs are active. Crucially, hs-CRP cannot tell you whether active resolution pathways have switched on to turn inflammation off. It is the smoke alarm's battery indicator — not a map of the room.
That's where whole-blood transcriptomics comes in. The Inflammation Compass™ measures the active messenger RNA (mRNA) inside your circulating white blood cells. By reading the transcriptional programs across Activation, Antiviral Response, and Resolution — and mathematically deconvolving which cell types are speaking — it provides a dynamic, biological window into systemic calming during GLP-1 therapy and tapering.
Standard Blood Tests (hs-CRP & CBC)
- ✕ Single liver protein snapshot (hs-CRP) with ~19h lag
- ✕ Blind to which inflammatory pathways are activated
- ✕ Zero visibility into active biological resolution
- ✕ Cell count census only — no activation states
Inflammation Compass™ (RNA Layer)
- ✓ Reads active gene expression inside circulating immune cells
- ✓ Maps 3 Health Domains: Activation, Antiviral, and Resolution
- ✓ Tracks active stand-down & tissue clearance machinery
- ✓ Cellular deconvolution separates cell numbers from cell states
Semaglutide vs. Tirzepatide:
Different Drugs, Different Monitoring
Ozempic and Mounjaro aren't the same drug — and they don't need the same monitoring. Semaglutide targets GLP-1 receptors only. Tirzepatide hits both GLP-1 and GIP receptors, creating a different metabolic profile that demands different attention.
Semaglutide
Ozempic® · Wegovy® · Rybelsus®
Mechanism
GLP-1 receptor agonist only — mimics the incretin hormone GLP-1 to slow gastric emptying, reduce appetite, and improve insulin sensitivity.
Key Monitoring Focus
- Thyroid function — highest priority given the GLP-1 C-cell warning
- Pancreatic enzymes — pancreatitis is a known semaglutide risk
- Kidney function — dehydration from nausea can stress kidneys
- Systemic inflammatory calming — whole-blood transcriptomics tracks whether innate immune pathways cool as visceral fat decreases
Tirzepatide
Mounjaro® · Zepbound®
Mechanism
Dual GLP-1/GIP receptor agonist — activates both incretin pathways simultaneously, producing more aggressive insulin sensitization and greater weight loss in trials.
Key Monitoring Focus
- Insulin & glucose dynamics — dual mechanism creates deeper glycemic shifts
- Liver enzymes — more aggressive fat mobilization means more hepatic processing
- Lipid metabolism — GIP pathway influences fat storage and breakdown differently
- Resolution signaling — monitoring whether deep metabolic changes trigger active immune resolution
Both drug classes benefit from whole-blood transcriptomic monitoring, which captures dynamic immune program shifts that routine protein labs miss. Whether you are on Ozempic or Mounjaro, standard labs provide essential clinical safeguards — while the Inflammation Compass™ provides a biological window into your immune arc.
Monitoring Is More Than
a Single Blood Draw
Understanding what to test is step one. You also need to know when to test, which biomarkers matter most, and how mRNA fills the gaps that standard labs leave wide open.
When to Test
Baseline, 4-week, 12-week, and ongoing schedules — timed to your titration and milestones.
View ScheduleGLP-1 Biomarkers
The complete biomarker deep dive — every gene expression target we track and why it matters.
Explore BiomarkersThe mRNA Layer
How gene expression testing fills the gaps between blood draws — catching problems weeks before labs do.
Learn More
Frequently Asked
Questions
What blood tests should I get on Ozempic?
Healthcare providers commonly evaluate a Comprehensive Metabolic Panel (CMP) to check liver and kidney function, a Lipid Panel for cholesterol and triglycerides, a Thyroid Panel (TSH + Free T4) given the FDA's boxed warning regarding rodent thyroid C-cell tumors, Inflammatory Markers like hs-CRP, and a Complete Blood Count (CBC). An HbA1c is also routinely monitored if you are managing diabetes. For deeper insight, mRNA gene expression testing captures early cellular shifts at the 1-month follow-up node, well before traditional blood markers reflect downstream changes.
How often should I get blood work on semaglutide?
Most providers recommend an initial starting baseline panel (whether before your first dose or upon entering monitoring), a follow-up at 4 weeks (or when you reach your first dose escalation), another at 12 weeks, and then every 3–6 months once you're on a stable dose. If you're also adding mRNA monitoring, those are typically aligned with your blood draws for a complete picture. See our testing schedule page for the full recommended timeline.
Do I need a thyroid test on GLP-1 medication?
Yes. All GLP-1 receptor agonists — including Ozempic, Wegovy, Mounjaro, and Zepbound — carry an FDA boxed warning about thyroid C-cell tumors observed in rodent studies. While the human relevance is still being evaluated, clinicians frequently monitor thyroid health. Routine evaluations often include TSH and Free T4, and some clinicians consider calcitonin (a marker for medullary thyroid carcinoma) for baseline screening. Individuals with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not take these medications.
What's the difference between monitoring for Ozempic vs. Mounjaro?
The core panels (CMP, lipids, thyroid, CBC) apply to both. The key difference is in emphasis. Ozempic (semaglutide) is a GLP-1-only drug, so thyroid and pancreatic monitoring are the top priorities. Mounjaro (tirzepatide) is a dual GLP-1/GIP agonist that tends to produce more aggressive weight loss and deeper glycemic shifts — so liver enzyme monitoring, insulin/glucose dynamics, and resolution signaling become proportionally more important. In both cases, whole-blood transcriptomics provides the critical biological window into systemic immune activity that standard protein tests miss.
What is mRNA testing and how is it different from regular blood work?
Standard blood tests measure the end products of biological processes — single protein levels like hs-CRP, enzyme concentrations, or static cell counts. By the time these numbers change, the underlying cellular shift happened weeks ago. mRNA testing measures gene expression — the messenger RNA instructions your circulating immune cells are actively transcribing right now. Rather than measuring a delayed liver protein or an uninformative cell headcount, the Inflammation Compass™ maps active biological programs across Activation, Antiviral Response, and Resolution pathways, giving you a dynamic window into systemic inflammatory calming. Learn more on our mRNA layer page.
Don't Fly Blind on
GLP-1 Therapy
Whether you're on Ozempic, Wegovy, Mounjaro, or Zepbound — get the cellular clarity standard blood work misses with mRNA monitoring from Biomeme Labs.